Establishing Prospective IVIVC for Generic Pharmaceuticals: Methodologies Assessment
نویسندگان
چکیده
The present study was aimed to establish prospective IVIVC method for generic products using example of two different drug formulations (aprepitant capsules, immediate release and donepezil tablets, sustained release). The in vitro dissolution of these formulations was examined by using USP-II apparatus and different range of dissolution media. The dissolution profile was matched with the deconvoluted profile of drugs obtained from literature data to select biorelevant dissolution media. An IVIVC was established by using the mean fraction dissolved (FD) and mean fraction absorbed (FA) and used to simulate the plasma profile of these formulations by convolution from optimized dissolution media. The in vivo drug disposition was studied in an open label, balanced, randomized, single dose, two way crossover study in healthy subjects. Predicted PK parameters were compared with observed parameters. A positive correlation was seen between the FD and FA for both formulations with r=0.989 for aprepitant and r=0.995 for donepezil. The percent prediction error for both Cmax and AUCt were ≤15% while predicting the plasma concentration time profile for human bioequivalence studies for these formulations. Results supports use of prospective method in establishing IVIVC while predicting in vivo pharmacokinetic profile for bioequivalence studies for generic product development.
منابع مشابه
Biopharmaceutics Classification System: A Regulatory Approach
The Biopharmaceutics Classification System (BCS) is the result of continuous efforts in mathematical analysis for the elucidation of the kinetics and dynamics of the drug process in the gastrointestinal tract (GIT) for NDA (New Drug Application) and ANDA (Abbreviated New Drug Application) filings and biowaivers. This step reduces timelines in the new drug development process, both directly and ...
متن کاملIn vitro - in vivo correlation: from theory to applications.
A key goal in pharmaceutical development of dosage forms is a good understanding of the in vitro and in vivo performance of the dosage forms. One of the challenges of biopharmaceutics research is correlating in vitro drug release information of various drug formulations to the in vivo drug profiles (IVIVC). Thus the need for a tool to reliably correlate in vitro and in vivo drug release data ha...
متن کاملIVIVC of parenteral PLGA microspheres
There have been only a dozen parenteral extended release formulations that are designed to deliver drugs from a week up to 6 months since the first introduction of Lupron Depot® made of poly(lactic-coglycolic acid) (PLGA) microspheres in 1989. All parenteral extended release formulations are made of PLGA in the form of microspheres, solid implants, and in situ forming implants. Over the past fe...
متن کاملIVIVC from Long Acting Olanzapine Microspheres
In this study, four PLGA microsphere formulations of Olanzapine were characterized on the basis of their in vitro behavior at 37°C, using a dialysis based method, with the goal of obtaining an IVIVC. In vivo profiles were determined by deconvolution (Nelson-Wagner method) and using fractional AUC. The in vitro and in vivo release profiles exhibited the same rank order of drug release. Further, ...
متن کامل